Hello, Fool! | Login | Signup | My Fool
Jul 5, 2008 12:14 AM ET | Site Changes | Help
Search: Tickers Company Names Players
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
View All Commentary (VRTX)
Recs
genedom (97.60) Submitted: 9/27/07 2:45 AM : Start Price: $37.99 VRTX Score: -6.81
A 5-billion dollar company with the drug approval two years away is too pricey for me. Not mention anything can happen in phase III trial.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.